Phenotypes associated with this allele
Allelic Composition |
Ercc1tm1Jhjh/Ercc1tm1Jhjh
|
|
Genetic Background |
either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB) |
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ercc1tm1Jhjh mutation
(0 available);
any
Ercc1 mutation
(15 available)
|
|
|
mortality/aging
|
• mutants do not live beyond 38 days of age
|
|
• many mutant embryos die by E13.5
|
growth/size/body
|
• on a mixed 129P2/OlaHsd and C57BL/6 background embryonic growth delay is seen
|
|
• homozygotes are severely runted
|
embryo
|
• on a mixed 129P2/OlaHsd and C57BL/6 background embryonic growth delay is seen
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ercc1tm1Jhjh mutation
(0 available);
any
Ercc1 mutation
(15 available)
|
|
|
mortality/aging
|
• most die by four weeks after birth
|
growth/size/body
|
• growth arrests in the second week of life
|
embryo
cellular
|
• apoptotic cells are increased in mutant liver compared to age-matched controls
|
|
• mutant ES cells and MEFs are mildly, but significantly, hypersensitive to oxidative damage compared to wild-type
|
|
• cellular proliferation is decreased compared to age matched controls
|
|
• senescent, polyploid hepatocytes are prominent in mutants but not age-matched controls
|
|
• MEFS exhibit premature replicative senescence
|
behavior/neurological
homeostasis/metabolism
liver/biliary system
|
• apoptotic cells are increased in mutant liver compared to age-matched controls
|
|
• senescent, polyploid hepatocytes are prominent in mutants but not age-matched controls
|
|
• triglyceride accumulation is observed in the liver in young mutants as is seen in older controls
|
muscle
renal/urinary system
skeleton
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ercc1tm1Jhjh mutation
(0 available);
any
Ercc1 mutation
(15 available)
|
|
|
mortality/aging
|
• mice die between 3 and 4 weeks of age
|
hematopoietic system
|
• decreased colony forming unit-granulocyte (CFU-G) and granulocyte-macrophage (CFU-GM) at 3 weeks
|
|
• decreased total LSK+ cells at 3 weeks
|
liver/biliary system
|
• cells with enlarged nuclei in the liver
|
growth/size/body
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ercc1tm1Jhjh mutation
(0 available);
any
Ercc1 mutation
(15 available)
|
|
|
cellular
|
• B cell proliferation is reduced to 76% wild-type
|
mortality/aging
|
• mutants die around 3 weeks of age from liver failure
|
hematopoietic system
|
• B cell proliferation is reduced to 76% wild-type
|
|
• class switching recombination for IgG1, IgG2a, IgG2b, IgG3, and IgA is reduced 20-55%
• the mutation spectra and location are altered in GL Smu segments
|
|
• at P19-21 spleen contain 10-fold fewer cells
|
immune system
|
• B cell proliferation is reduced to 76% wild-type
|
|
• class switching recombination for IgG1, IgG2a, IgG2b, IgG3, and IgA is reduced 20-55%
• the mutation spectra and location are altered in GL Smu segments
|
|
• at P19-21 spleen contain 10-fold fewer cells
|
liver/biliary system
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ercc1tm1Jhjh mutation
(0 available);
any
Ercc1 mutation
(15 available)
Ercc1tm2Jhjh mutation
(0 available);
any
Ercc1 mutation
(15 available)
|
|
|
hematopoietic system
|
• at 3, 10 and 20 weeks
• decreased colony forming unit-granulocyte (CFU-G) and granulocyte-macrophage (CFU-GM) at 3, 10 and 20 weeks
|
|
• decreased total LSK+ cells with a 3-fold decrease in the fraction of multipotent progenitors (MPP) but an increase in the fraction of long term hematopoietic stem cells (HSCs) at 3 weeks; increased fraction of short term HSCs but a decrease in MPP at 10 and 20 weeks
|
liver/biliary system
|
• cells with enlarged nuclei in the liver
|
growth/size/body
|
• at 3, 10 and 20 weeks of age
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ercc1tm1Jhjh mutation
(0 available);
any
Ercc1 mutation
(15 available)
Ercc1tm2Jhjh mutation
(0 available);
any
Ercc1 mutation
(15 available)
|
|
|
hearing/vestibular/ear
|
• at 5 weeks of age with further deterioration at 9 weeks at 8 and 16, but not 4, kHz
|
|
• reduced at 12, but not 4, weeks
|
vision/eye
|
• in the outer nuclear layer at 4, 9, 18 and 25 weeks
|
|
• progressive starting at 25 weeks
|
nervous system
behavior/neurological
|
• progressive reduction at 10 and 14 weeks
• smaller saccades at all ages
• however, the main sequence is normal
|
cellular
|
• in the outer nuclear layer at 4, 9, 18 and 25 weeks
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ercc1tm1Jhjh mutation
(0 available);
any
Ercc1 mutation
(15 available)
Ercc1tm3Jhjh mutation
(0 available);
any
Ercc1 mutation
(15 available)
Tg(Tek-cre)12Flv mutation
(1 available)
|
|
|
hematopoietic system
N |
• mice exhibit normal blood cell parameters and colony-forming progenitors in the bone marrow
|